ThermoGenesis Expands European Distribution Of CryoSeal(R) Fibrin Sealant (FS) System And Thrombin Processing Device(TM) (TPD) To Czech Republic, Slovakia And Greece

RANCHO CORDOVA, Calif., June 14 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL - News) today announced that the Company signed exclusive agreements with distributors in the Czech Republic, Slovakia and Greece for its CE-Marked CryoSeal FS System, which produces fibrin surgical sealant from a patient's own blood in about an hour. The two distributors also signed agreements to be the non-exclusive distributors of the TPD, which produces activated thrombin in less than 30 minutes for platelet gel preparation.
MORE ON THIS TOPIC